(Q53186086)
Statements
Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective. (English)
Jonathan Karnon
Thomas Delea
Vicki Barghout
30 June 2007
9
2
171-183